You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Treatment free remission

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Treatment Free Remission (TFR) in CML Patients (CML-CP)Study

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Treatment-free Remission
  • TFR(Treatment-Free Remission)
  • (no location specified)
Jun 27, 2022

CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

Recruiting
  • CML
  • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
  • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
    FUNDALEU
Jun 29, 2023

Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

Not yet recruiting
  • Chronic Myeloid Leukemia, BCR/ABL-Positive
    • Taipei, Taiwan
      National Taiwan University Hospital
    Jul 24, 2022

    Treatment Free Remission, Chronic Myeloid Leukemia Trial in Turin

    Recruiting
    • Treatment Free Remission
    • Chronic Myeloid Leukemia
      • Turin, Italy
        Division of Hematology-AO Mauriziano Hospital, University of Tur
      Nov 17, 2021

      Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia
      • Detroit, Michigan
      • +1 more
      May 3, 2022

      Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

      Not yet recruiting
      • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
      • (no location specified)
      Jun 7, 2022

      Outcomes of Tyrosine Kinase Inhibitor(TKI)Stopping in Chronic

      Recruiting
      • Folate
      • +2 more
        • Nantong, China
          Affliated Hospital of Nantong University
        Dec 13, 2021

        Progression Free Survival, Overall Survival, Maintenance Trial (Ixazomib DX/Lenalidomide DX)

        Not yet recruiting
        • Progression Free Survival
        • +2 more
        • Ixazomib DX/Lenalidomide DX
        • (no location specified)
        Jul 27, 2022

        Exploration of Cluster Headache in a PET-MRI Study

        Not yet recruiting
        • Cluster Headache, Episodic
        • PET-MRI in pain-free remission period
        • (no location specified)
        Oct 18, 2021

        Ulcerative Colitis, Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate Trial in Worldwide (Ulcerative colitis

        Not yet recruiting
        • Ulcerative Colitis
        • +2 more
        • Ulcerative colitis Exclusion Diet
        • +3 more
        • Afula, Israel
        • +5 more
        Mar 16, 2023

        Acute Myeloid Leukemia Trial in Houston (Decitabine and Cedazuridine, Enasidenib, Gilteritinib)

        Recruiting
        • Acute Myeloid Leukemia
        • Decitabine and Cedazuridine
        • +4 more
        • Houston, Texas
          M D Anderson Cancer Center
        Aug 10, 2022

        PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer

        Recruiting
        • Immune Checkpoint Inhibitors
        • +9 more
        • Radiotherapy for targeted lesions and PD-1 antibody
        • Beijing, Beijing, China
          Lei Li
        Apr 1, 2022

        Survival in Adult MRD Positive Acute Lymphoblastic Leukemia

        Completed
        • Acute Lymphoblastic Leukemia
          • Brno, Czechia
          • +9 more
          Sep 12, 2022

          Chronic Myeloid Leukemia Trial in Worldwide (nilotinib)

          Active, not recruiting
          Has Results
          • Chronic Myeloid Leukemia
          • Los Angeles, California
          • +61 more
          Mar 17, 2022

          Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic

          Withdrawn
          • CLL
          • +4 more
          • Treatment Free Observation
          • Basking Ridge, New Jersey
          • +8 more
          Mar 4, 2022

          Leukemia, Chronic Myeloid Trial in Campinas (Pioglitazone, imatinib discontinuation)

          Active, not recruiting
          • Leukemia, Chronic Myeloid
          • Campinas, SP, Brazil
            Centro de Hematologia e Hemoterapia - Universidade Estadual de C
          Nov 2, 2020

          Non-Hodgkin's Lymphoma, Acute Leukemia in Remission, Chronic Myeloid Leukemia Trial in Tampa (drug, radiation, procedure)

          Completed
          Has Results
          • Non-Hodgkin's Lymphoma
          • +7 more
          • Tampa, Florida
            H. Lee Moffitt Cancer Center and Research Institute
          Sep 14, 2021

          Chronic Myelogenous Leukemia Trial in Worldwide (Nilotinib followed by treatment-free)

          Active, not recruiting
          Has Results
          • Chronic Myelogenous Leukemia
          • Nilotinib followed by treatment-free
          • Fort Myers, Florida
          • +113 more
          Apr 25, 2022

          Crohn Disease Trial in Philadelphia (Crohn Disease Exclusion Diet, Free Diet)

          Completed
          Has Results
          • Crohn Disease
          • Crohn Disease Exclusion Diet
          • Free Diet
          • Philadelphia, Pennsylvania
            The Children's Hospital of Philadelphia
          Sep 29, 2020

          Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Worldwide (procedure, other, drug)

          Recruiting
          • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
          • Biospecimen Collection
          • +4 more
          • Birmingham, Alabama
          • +170 more
          Jan 30, 2023

          Chronyc Myeloid Leukemia Trial in Italy, Netherlands (Imatinib, Nilotinib)

          Active, not recruiting
          • Chronyc Myeloid Leukemia
          • Alessandria, Italy
          • +81 more
          Jan 4, 2022

          Chronic Myeloid Leukemia Trial in Canada (Dasatinib)

          Unknown status
          • Chronic Myeloid Leukemia
          • Calgary, Alberta, Canada
          • +11 more
          Nov 27, 2019

          A 12-month Real Life Study of IBD Patients Switched From

          Recruiting
          • IBD Patients, Originator Treatment, Biosimilar, Switch Back
            • Grenoble Cedex 9, France
              Chu Grenoble Alpes
            Sep 28, 2020

            Ulcerative Colitis Trial in Belgium (5-ASA)

            Recruiting
            • Ulcerative Colitis
            • Bonheiden, Belgium
            • +15 more
            Aug 11, 2023

            Inflammatory Disease, Disease Crohn, Bowel Disease Trial in Amsterdam (Infliximab subcutaneous, Immunosuppressive Agents)

            Recruiting
            • Inflammatory Disease
            • +2 more
            • Infliximab subcutaneous
            • Immunosuppressive Agents
            • Amsterdam, North Holland, Netherlands
              Amsterdam UMC AMC
            Sep 27, 2023